A day after the Boston Scientific deal was announced Stryker also inked a deal for bio-implantable products maker Porex Surgical Inc. for an undisclosed amount. According to Stryker officials, the cranial implant maker’s assets will complement its existing craniomaxillofacial product offering.
Porex Surgical develops bio-implantable porous polyethylene products for use in reconstructive surgery of the head and face. Its parent company, Porex Corp., based in Fairburn, Ga., manufactures porous plastic products for a variety of industries. Porex is owned by Los Angeles, Calif.-based investment firm Aurora Capital Group.